LABD

Direxion Daily S&P Biotech Bear 3X Shares · PSE

Category Health Care
Expense Ratio 1.1%
Listing Date May 28, 2015
Volume 23,385,881.0
Market Cap (AUM) $66.11M

Performance

+20.0%

+16.61%

+20.32%

-15.12%

-29.75%

YTD

-62.73%

Top Holdings

Name
Symbol
%Assets
U.S. DollarN/A100.00%

Advanced Technical Analysis

Technical Analysis of LABD 2024-11-20

The stock exhibits a bullish sentiment overall, with a strong Moving Average Score of 76 indicating positive momentum, while the Technical Score of 63 further supports this outlook. However, the Oscillators Score of 50 suggests a neutral stance, indicating potential consolidation or indecision in the market.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Recent News & Updates

2023-02-22 22:45
This Year's Most Shorted ETFs(Yahoo Finance)
2022-05-01 23:10
5 Inverse ETFs That Are Up More Than 60% in April(Yahoo Finance)
2020-07-27 06:47
Direxion Announces Reverse Splits of Six Daily Leveraged ETFs(Yahoo Finance)
2020-02-09 20:39
3 Leveraged Healthcare ETFs Soaring This Month(Yahoo Finance)
2019-10-08 22:10
6 Best Leveraged Inverse ETFs of Past Week(Yahoo Finance)
2019-06-03 22:43
Day Trading With Leveraged ETFs(Investopedia)
2019-05-22 22:10
5 Leveraged/Inverse ETFs That Are Up 20% Plus So Far in Q2(Yahoo Finance)
2019-04-09 02:26
In the Age of Algorithms(Thestreet)
2019-04-08 21:25
Big Moves In Leveraged Biotech ETFs(Yahoo Finance)
2019-01-13 21:05
This Biotech ETF Is Soaring, But A Bearish Friend Lures Traders(Yahoo Finance)
2018-12-20 21:58
7 Inverse ETFs That Soared More Than 70% in Q4(Yahoo Finance)
2018-11-13 02:57
The Time Could Be Right For This Biotech ETF(Yahoo Finance)
2018-10-08 23:59
7 Leveraged/Inverse ETFs Off to a Strong Start in October(Yahoo Finance)
2018-07-18 00:27
Exploring The Leveraged ETF Trade Heading Into Earnings Season(Yahoo Finance)
2018-03-27 23:43
For Now, Traders Endorse Biotech Rally(Yahoo Finance)
2018-02-28 03:30
Direxion Announces Reverse Splits of Five ETFs(Yahoo Finance)
2017-11-29 03:46
Short Interest And Leveraged ETFs(Yahoo Finance)
2017-11-15 00:18
How venture philanthropy is helping to find a diabetes cure(Yahoo Finance)
2017-11-14 02:49
Latest Tax Reform Bill From Senate GOP Seeks Repeal Of ACA Individual Mandate(Yahoo Finance)
2017-11-14 01:13
GE made a mistake slashing its dividend, and the entire Dow is paying the price today: NYSE trader(Yahoo Finance)
2017-11-13 21:33
Yellen, Draghi, Carney and Kuroda met in Frankfurt todayhere's what went down(Yahoo Finance)
2017-11-13 00:45
The biggest market-mover this week is the 'argy bargy' on taxes down in the Beltway: NYSE trader(Yahoo Finance)
2017-11-09 22:05
Nvidia and Intel are set to be long-term market leaders(Yahoo Finance)
2017-11-09 21:55
Stocks have bigger problems than tax reform(Yahoo Finance)
2017-11-09 04:20
3 signs the bulls are still kicking(Yahoo Finance)
2017-11-05 22:10
Why the Broadcom bid for Qualcomm may end in a proxy battle(Yahoo Finance)
2017-08-31 04:37
A Sign Of Things To Come? Traders Are Betting On More Biotech Mergers(Yahoo Finance)
2017-07-27 02:43
4 Things To Know Before Trading A Leveraged ETF(Yahoo Finance)
2017-07-12 23:00
This Market Action Is Once Again Sluggish(Thestreet)
2017-06-29 23:38
Fourth of July Fireworks May Be at Hand, but Today's Action Is a Dud(Thestreet)
2017-06-27 22:45
The Market Is Going Green, Yet Again(Thestreet)
2017-02-17 00:40
Biotech 2017: 4 Ideas for A Stockpicker's Year(Barrons)
2017-01-11 02:14
What pharma investors ought to do after Donald Trump fires a salvo(Marketwatch)
2017-01-01 12:00
NVDA, LABD, TWM: Rev Shark's Views(Thestreet)
2016-12-27 22:24
Dip Buying Wanes at Year's End(Thestreet)
2016-12-07 21:34
How Will Trumps Take on the ACA Affect Healthcare Stocks?(Marketrealist)
2016-11-07 20:34
Which Sectors to Invest in If Donald Trump Wins(Marketrealist)
2016-10-16 22:10
ETFs to Play as Biotech Juggles Election & Earnings(Yahoo Finance)
2016-10-14 03:26
Can Biotech Stocks Stay Trendy?(Yahoo Finance)
2016-09-29 02:00
LABD Rallies as Mylan, Biotechs Slump (LABD)(Investopedia)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.